Preview

Systemic Hypertension

Advanced search

The frequency of hypertension and other risk factors in patients undergoing large joint arthroplasty: a real-world study

https://doi.org/10.38109/2075-082X-2023-1-29-34

Abstract

Background. The population of patients undergoing large joints arthroplasty has a high prevalence of comorbidities, such as hypertension and other cardiovascular diseases, obesity, diabetes, chronic kidney disease, etc., that are independent risk factors for the postoperative complications, especially of the thromboembolic events.

Aim. To evaluate the prevalence of hypertension and other risk factors in patients undergoing large joint arthroplasty in real-world practice.

Materials and methods. The study included an unselected sample of patients (n=82) who underwent arthroplasty of large joints in December 2022 at the Clinic of Traumatology, Orthopedics and Joint Pathology of the I.M. Sechenov First Moscow State Medical University. A detailed history was collected from all patients and, if necessary, a laboratory and instrumental examination was performed to assess the presence of target organ damage.

Results. Sixty-two patients (81.7%) had hypertension; among them 12.6% had no previous antihypertensive therapy. The average body mass index (BMI) was 31.3±5.2 kg/m2 confirming the high prevalence of obesity in this population. All obese patients had concomitant hypertension (n=62), and 6 people (7.3%) with a BMI over 40 kg/m2 had signs of obstructive sleep apnea syndrome. Diabetes mellitus (DM) was diagnosed in 13 people (15.9%); in all cases it was type 2 diabetes. Chronic kidney disease (CKD) stage 2-4 was diagnosed in 67 people (81.7%), and all these patients had concomitant obesity and hypertension.

Conclusion. Based on the analysis of published literature and a sample of patients from real-world practice, the main population undergoing the arthroplasty of large joints include elder patients, and the vast majority of them have multiply comorbidities (obesity, hypertension, CKD) that are not only the independent risk factors for poor prognosis, but also exacerbate the other concomitant conditions and further increase the risk of complications. It is necessary to conduct large prospective studies with specific evaluation of various cohorts of patients undergoing arthroplasty of large joints including a pharmacoeconomic analysis to determine the need and scope of further examination in this population with a high risk of perioperative complications.

About the Authors

E. A. Okisheva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Elena A. Okisheva, Assistant of the Department of Faculty Therapy No. 1

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



M. D. Madoyan
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Maria D. Madoyan, medical student

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



S. E. Fidanyan
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Svetlana E. Fidanyan, medical student

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



A. I. Semenova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Aida I. Semenova, medical resident

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



A. S. Panferov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Alexandr S. Panferov, Cand. Sci. (Med.), Professor of the Department of Faculty Therapy No. 1

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



O. Iu. Mironova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Olga Iu. Mironova, Dr. Sci. (Med.), Professor of the Department of Faculty Therapy No. 1, N.V. Sklifosovsky Institute of Clinical Medicine

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



A. V. Lychagin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Alexey V. Lychagin, Dr. Sci. (Med.), Professor, Head of the Department of Department of Traumatology, Orthopedics and Disaster Surgery, N.V. Sklifosovsky
Institute of Clinical Medicine

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



V. V. Fomin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Viktor V. Fomin, corresponding member of RAS, Professor, Dr. Sci. (Med.), Vice-Rector for Innovation and Clinical Activities, Head of the Department of Faculty Therapy No. 1, N.V. Sklifosovsky Institute of Clinical Medicine

st. Trubetskaya, 8, building 2, Moscow 119991, Russian Federation



References

1. Середа А.П., Кочиш А.А., Черный А.А., Антипов А.П., Алиев А.Г, Вебер Е.В., Воронцова Т.Н., Божкова С.А., Шубняков И.И., Тихилов Р.М. Эпидемиология эндопротезирования тазобедренного и коленного суставов и перипротезной инфекции в российской федерации. Травматология и ортопедия России. 2021;27(3):84-93. [Sereda A.P., Kochish A.A., Cherny A.A., et al. Epidemiology of Hip And Knee Arthroplasty and Periprosthetic Joint Infection in Russian Federation. Traumatology and Orthopedics of Russia. 2021; 2021;27(3):84-93 (In Russ.)]. https://doi.org/10.21823/2311-2905-2021-27-3-84-93

2. Ferguson R.J., Palmer A.J., Taylor A., Porter M.L., Malchau H., Glyn-Jones S. Hip replacement. Lancet. 2018;392(10158):1662-1671. https://doi.org/10.1016/S0140-6736(18)31777-X

3. Лычагин А.В., Гаркави А.В., Мещеряков В.А., и др. Остеоартроз коленного сустава у пожилых — всегда ли оправдано эндопротезирование? Вестник Российского государственного медицинского университета. 2019;2:77–82. [Lychagin AV, Garkavi AV, Meshcheryakov VA, Kaykov VS. Osteoarthritis of the knee in the elderly: is knee replacement always justified? Bulletin of RSMU. 2019;2:70–5. (In Russ.)]. https://doi.org/10.24075/vrgmu.2019.020

4. Божкова С.А., Тихилов Р.М., Андрияшкин В.В., Ахтямов И.Ф., Белов М.В., Дианов С.В., Касимова А.Р., Каплунов О.А., Копенкин С.С., Маланин Д.А., Муштин Н.Е., Цед А.Н. Профилактика, диагно- стика и лечение тромбоэмболических осложнений в травматологии и ортопедии: методические рекомендации. Травматология и ортопедия России. 2022;28(3):136-166. [Bozhkova S.A., Tikhilov R.M., Andriyashkin V.V., et al. Prevention, Diagnosis and Treatment of Thromboembolic Complications in Traumatology and Orthopedics: Methodological Guidelines. Traumatology and Orthopedics of Russia. 2022;28(3):136-166 (In Russ.).]. https://doi.org/10.17816/2311-2905-1993

5. Nwachukwu, B.U., Collins, J.E., Nelson, E.P. et al. Obesity & hypertension are determinants of poor hemodynamic control during total joint arthroplasty: a retrospective review. BMC Musculoskelet Disord 14, 20 (2013). https://doi.org/10.1186/1471-2474-14-20

6. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57. https://doi.org/10.1016/S0140-6736(06)68770-9

7. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23. https://doi.org/10.1016/S0140-6736(05)17741-1

8. Organization WH. World health statistics 2012 [internet]. Genebra: WHO; 2012. 9. Tian S, Dong G-H, Wang D, Liu M-M, Lin Q, Meng X-J, Xu L-X, Hou H, Ren Y-F. Factors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE study. Hypertens Res. 2011;34(10):1087–92. https://doi.org/10.1038/hr.2011.99

9. Agyemang C, Van Valkengoed I, Koopmans R, Stronks K. Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, the Netherlands: the SUNSET study. J Hum Hypertens. 2006;20(11):874–81. https://doi.org/10.1038/sj.jhh.1002073

10. Mortazavi SMJ, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH: Perioperative stroke after total joint arthroplasty: prevalence. predictors and outcome. J Bone Joint Surg Am. 2010, 92: 2095-2101. https://doi.org/10.2106/jbjs.i.00940

11. Mantilla C.B., Horlocker T.T., Schroeder D.R. et al. Frequency of Myocardial Infarction, Pulmonary Embolism, Deep Venous Thrombosis, and Death following Primary Hip or Knee Arthroplasty. Anesthesiology 2002; 96: 1140–1146. https://doi.org/10.1097/00000542-200205000-00017

12. Purdy JC, Shatzel JJ. The hematologic consequences of obesity. Eur J Haematol 2021;106(03):306–319. https://doi.org/10.1111/ejh.13560

13. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010;8(10):2105–2112. https://doi.org/10.1111/j.1538-7836.2010.03986.x

14. Schlaudecker J, Becker R. Inflammatory response and thrombosis in older individuals. Semin Thromb Hemost 2014;40(06): 669–674. https://doi.org/10.1055/s-0034-1387882

15. Senaratna CV, Perret JL, Lodge CJ, et al: Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev 2017;34:70-81. https://doi.org/10.1016/j.smrv.2016.07.002

16. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM: Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-1014. https://doi.org/10.1093/aje/kws342

17. D’Apuzzo MR, Browne JA: Obstructive sleep apnea as a risk factor for postoperative complications after revision joint arthroplasty. J Arthroplasty 2012;27:95-98. https://doi.org/10.1016/j.arth.2012.03.025

18. Tang, Alex MD; Aggarwal, Vinay K. MD; Yoon, Richard S. MD; Liporace, Frank A. MD; Schwarzkopf, Ran MD, MSc. The Effect of Obstructive Sleep Apnea on Venous Thromboembolism Risk in Patients Undergoing Total Joint Arthroplasty. JAAOS: Global Research and Reviews 6(4):e21.00248, April 2022. https://doi.org/10.5435%2FJAAOSGlobal-D-21-00248

19. Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with diabetes mellitus. Am J Med. 2012; 125(7):709–16. https://doi.org/10.1016%2Fj.amjmed.2011.12.004

20. Li Q, Dai B, Yao Y, Song K, Chen D, Jiang Q. Chronic Kidney Dysfunction Can Increase the Risk of Deep Vein Thrombosis after Total Hip and Knee Arthroplasty. Biomed Res Int. 2017;2017:8260487. https://doi.org/10.1155/2017/8260487

21. L. C.Warth, A. J. Pugely, C. T. Martin, Y. Gao, and J. J. Callaghan, Total joint arthroplasty in patients with chronic renal disease: is it worth the risk? Journal of Arthroplasty, vol. 30, no. 9, pp. 51–54, 2015. https://doi.org/10.1155/2017/8260487


Review

For citations:


Okisheva E.A., Madoyan M.D., Fidanyan S.E., Semenova A.I., Panferov A.S., Mironova O.I., Lychagin A.V., Fomin V.V. The frequency of hypertension and other risk factors in patients undergoing large joint arthroplasty: a real-world study. Systemic Hypertension. 2023;20(1):29-34. (In Russ.) https://doi.org/10.38109/2075-082X-2023-1-29-34

Views: 944


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)